Myocardial function and structure improvement with sacubitril/valsartan in cancer therapy-induced cardiomyopathy-Reference-Cited by-同舟云学术

Myocardial function and structure improvement with sacubitril/valsartan in cancer therapy-induced cardiomyopathy

Published:2020-03 Issue:3 Volume:73 Page:268-269
ISSN:1885-5857
Container-title:Revista Española de Cardiología (English Edition)
language:en
Short-container-title:Revista Española de Cardiología (English Edition)

Author:

Martín-García Ana,Díaz-Peláez Elena,Martín-García Agustín C.,Sánchez-González Javier,Ibáñez Borja,Sánchez Pedro L.

Publisher

Elsevier BV

Subject

General Medicine

Reference4 articles.

1. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med,2014

2. First Magnetic Resonance Managed by a Cardiology Department in the Spanish Public Healthcare System. Experience and Difficulties of an Innovative Model;Barreiro-Perez;Rev Esp Cardiol (Engl Ed),2018

3. The use of sacubitril/valsartan in anthracycline-induced cardiomyopathy: A mini case series;Sheppard;J Oncol Pharm Pract.,2019

4. Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients;Almufleh;Am J Cardiovasc Dis,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Codiotoxicity of anthraciclines and the possibilities of its correction;South Russian Journal of Therapeutic Practice;2023-09-25

2. Pharmacotherapy for Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Childhood Cancer Survivors;Pediatric Drugs;2023-08-28

3. Comentarios a la guía ESC 2022 sobre cardio-oncología;Revista Española de Cardiología;2023-06

4. Effectiveness of sacubitril/valsartan for patients with cancer therapy‑related cardiac dysfunction: A systematic review of descriptive studies;Oncology Letters;2023-02-02

5. Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity;Cancers;2023-01-03